These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. ; Bohlius J; Schmidlin K; Costagliola D; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Karafoulidou A; Miro JM; Lundgren J; Chene G; Egger M Antivir Ther; 2009; 14(8):1065-74. PubMed ID: 20032536 [TBL] [Abstract][Full Text] [Related]
24. Contributions of HIV to Non-Hodgkin Lymphoma Mortality Trends in the United States. Howlader N; Shiels MS; Mariotto AB; Engels EA Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1289-96. PubMed ID: 27418269 [TBL] [Abstract][Full Text] [Related]
25. Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas. Warlick ED; Tomblyn M; Cao Q; Defor T; Blazar BR; Macmillan M; Verneris M; Wagner J; Dusenbery K; Aurora M; Bachanova V; Brunstein C; Burns L; Cooley S; Kaufman D; Majhail NS; McClune B; McGlave P; Miller J; Oran B; Slungaard A; Vercellotti G; Weisdorf DJ Biol Blood Marrow Transplant; 2011 Jul; 17(7):1025-32. PubMed ID: 21047561 [TBL] [Abstract][Full Text] [Related]
26. Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. Gérard L; Galicier L; Maillard A; Boulanger E; Quint L; Matheron S; Cardon B; Meignin V; Oksenhendler E J Acquir Immune Defic Syndr; 2002 Aug; 30(5):478-84. PubMed ID: 12154338 [TBL] [Abstract][Full Text] [Related]
27. Epidemiology of haematological malignancies in people living with HIV. Kimani SM; Painschab MS; Horner MJ; Muchengeti M; Fedoriw Y; Shiels MS; Gopal S Lancet HIV; 2020 Sep; 7(9):e641-e651. PubMed ID: 32791045 [TBL] [Abstract][Full Text] [Related]
28. Brief Report: HIV-Associated Hodgkin Lymphoma Involving the Bone Marrow Identifies a Very High-Risk Subpopulation in the Era of Widescale Antiretroviral Therapy Use in Johannesburg, South Africa. Vaughan J; Perner Y; McAlpine E; Wiggill T J Acquir Immune Defic Syndr; 2020 Apr; 83(4):345-349. PubMed ID: 32097194 [TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan. Yotsumoto M; Hagiwara S; Ajisawa A; Tanuma J; Uehira T; Nagai H; Fujikawa Y; Maeda S; Kitano K; Arima N; Uno K; Iwai T; Hongo I; Ota Y; Fukutake K; Okada S Int J Hematol; 2012 Aug; 96(2):247-53. PubMed ID: 22752537 [TBL] [Abstract][Full Text] [Related]
30. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms. Franceschi S; Dal Maso L; La Vecchia C Int J Cancer; 1999 Nov; 83(4):481-5. PubMed ID: 10508483 [TBL] [Abstract][Full Text] [Related]
31. Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan. Yang CJ; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC J Microbiol Immunol Infect; 2010 Aug; 43(4):278-84. PubMed ID: 20688287 [TBL] [Abstract][Full Text] [Related]
32. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART). Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362 [TBL] [Abstract][Full Text] [Related]
33. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden. Samuelsson BO; Ridell B; Röckert L; Gustafsson G; Márky I J Pediatr Hematol Oncol; 1999; 21(2):103-10. PubMed ID: 10206455 [TBL] [Abstract][Full Text] [Related]
34. Population-based surveillance of HIV-associated cancers: utility of cancer registry data. Clarke CA; Glaser SL J Acquir Immune Defic Syndr; 2004 Aug; 36(5):1083-91. PubMed ID: 15247562 [TBL] [Abstract][Full Text] [Related]
35. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta. Gingues S; Gill MJ HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981 [TBL] [Abstract][Full Text] [Related]
36. Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphoma. Wang L; Zheng Y; Luo R; Kang K; Niedermann G; Zhao A; Wu Y J Cancer Res Clin Oncol; 2024 Jan; 150(2):41. PubMed ID: 38280006 [TBL] [Abstract][Full Text] [Related]
37. HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytes. Bohlius J; Schmidlin K; Boué F; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Paparizos V; Miro JM; Obel N; Prins M; Chêne G; Egger M; Blood; 2011 Jun; 117(23):6100-8. PubMed ID: 21368291 [TBL] [Abstract][Full Text] [Related]
38. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy. Chao C; Xu L; Abrams D; Leyden W; Horberg M; Towner W; Klein D; Tang B; Silverberg M AIDS; 2010 Jul; 24(11):1765-70. PubMed ID: 20453630 [TBL] [Abstract][Full Text] [Related]
39. [HIV-associated malignant lymphomas]. Egli F; Baumann R; Bernasconi E; Opravil M Schweiz Med Wochenschr; 1992 Apr; 122(14):495-502. PubMed ID: 1348590 [TBL] [Abstract][Full Text] [Related]
40. Characterization of HIV-associated Hodgkin's lymphoma in HIV-infected patients: a single-center experience. Ruiz M; Parsons C; Cole J J Int Assoc Physicians AIDS Care (Chic); 2012; 11(4):234-8. PubMed ID: 22302202 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]